<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Our suggested approach to antithrombotic therapy in hospitalized patients with multisystem inflammatory syndrome in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Our suggested approach to antithrombotic therapy in hospitalized patients with multisystem inflammatory syndrome in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Our suggested approach to antithrombotic therapy in hospitalized patients with multisystem inflammatory syndrome in children</div><div class="cntnt"><img src="data:png;base64,iVBORw0KGgoAAAANSUhEUgAAAb4AAAIfBAMAAAD9C6QMAAAACXBIWXMAAAPoAAAD6AG1e1JrAAAAJ1BMVEX///8AAACIiIgoKCi7u7tERERgYGCcnJzd3d0RERHMzMzu7u53d3f0rhX3AAAgAElEQVR42uydz3PbxhXHFyABUrQOegJEUpIPoFnGddsDITuSKvkAmJ606gmkp0mm1gFUIqZ1egBNp6mTC2lNPIl7sVxPlUg9kM1MUt0oKWnHk4tcz3jamf5RfW8J/bIpVVFgEdTsGw9FE+SSn/nuw36xS75lTIQIESJEiBAh4uyEBKcVPeI7c28k+ASf4As1X3Ro967t/1dnrHTMJmUnbHwqaNZ+uoN80vX/yydZ+/7Ijv/M0v6X9JTPVccO5zuGfpLVTb9SaPRz2e9lmMF/38JDFoEr2mgzozVZ3Eza5irqtwTIdwPcKrgT51YK4LE4aG0WNYeXYDtrzpahatdgRrpOLwSnJMNYGT6EVEmBm5KZCgFfrtVcXG8+t9tcP125tTroMtVhtvUm8i2Sfr+OpllsPCvnV2IP8UUNjw0YrJJ4nP3TimTZBmNXpev4Qh37Zwv1VPPYP7PfTUhGNgz61VihCtrgqMH7p/oeQJ5FPOyfFeSb4v0znq5B+knhjwBpliiiiI06m2Jv5dgU8rF/QBKfqb6XR74aY5eA+CrsNcmqhSD/0lw/xhJpFh1Hvlur9Ljj81USHb6rsbT68/YKHcpv+PrpxOfZrNqeJL5bYyrpF08N5uc7+oWAD7Qmz7+kDS47Z14ZUt0M3qP843xfah2+jJaOD7MCShtdNj28ofxDPhWqbAk4n1vWeP4VtXy1k3+95xP+RfAJvjDx2fv/oxhHHPRjsruf2fOiveQ7YKRKTLe78clO58Pa3fhi+Zf4uMnjLymFjI8dwrejXhc+dALh5YtBam6UW8pvtNGvIaWbGtnO2rvLK7KpmSnFTMbN8w1YcApgMH4waqakWgXoUMR4gk6mjY9ETT6JZJsz0i9B24J8WdvEl6AP7bl+j2JrZCnv6Irb6Z9oO90B4+7mdMNYVNzWV+76Neyfjzr6WW8OeHcll7F38NDXeRy/CwwfGdjmytrNCurXuDMkz0YuOGhWe98/42nGLeUd9B9+/uFnbNSle45k5RRDqnnKbUd+O+33z0oDoGHJyxoe+vjxFPHRI/UOH8tKv+JtASy8jWa153zz7JG8RpaS+OaRr835BoxLmx2+6n23dS3v60cHBzzMsYb3DA/Vs3g10WgPkB3NsEfENym9gW2Ny7OYfyvUfI/5qjz/0FISXzWlb2mcL4r5x/lgGPMvsbzgzGH+8YNRU5MsBS7jIbZh0PkFH4mBmcBubsO0dH3Z/NjMl+E25h/60L4d3+nUOtfeHR+yg0b34bGf+a7ujO8yPD5s+Bf+TPC94rctHK89a8+uHvCt4eDzTZiBQxcrJvEe3mS09pzWZAsHvfV+RyZZu4b6IJ8eTr6so7pMnv3Mo5uPxiLbjwbz5z4/3HHum/4MoX5xM6nAzSqOeGaqAei6/vNbpsIVdRs/H95cyMu/GY8OxRzJTELepjkZ+zbMdPhoGrQ8WobGG67ybxMFxzYUI6PR9GkZDJ1bVegtn+qw7HcTxGdkSb8IuTD2O8VQXJRAWXDkK0PRdMSTjHc+1W2aUzNazcUd/Rq3p6l/Xk+37rufNZlkXFJ+sjp4a3VwYRr7J1nVjivtHR9+0gp7jfisGu+fqB8m2gv6rSNFDq0bnxOtsUKHDz3rH1yef6XnEQBybfYnFwGmACZd4kOrWrfDoJ/96STx5Tv5F2kuUv4t7uXff30+Pifa0W/AIM9K+nmSdfcx5izl3zPUjyVWMXW3OJ/vSnudf8oo8SWWXf/8OUOnzsd7589Vn4/PicqYfwDrbT4NWhxV8WIi4sRNqDMJrmD+gZuB980/cz7flYZx/Is5h01A8PjXMd+Du9Iz6198Vyr8meAL+G33e5EDi+o5/+8++8Win/c5375JxBx/WN/l4/C5OCTPlH76Af3YRh2Hxf7i2/OStKgu+TOcMowohql9BWkNvAJ4T+FvzlNoRgxaz+0rvl0vyRfV0Z5yL9miGTUW2dbZMF+LT6G4KbRBhrzSb/1zx0tO0aI62hvuJWuYfz8tg4v9MzYNkM4mN51ssq0aL0zS9wHfjpdM0KI68pGXJPOpXByPuCnky5NkA7cdNuBFjL47f+56Sb6ojnzoJWm1/nXlx6bmltPIV4DZZW3z5rLW3qj3m35dveShR3JnwL/4XrJb9OH4Lvyn4BN8gk/wHTWGn+3fr5wohtjZDsEn+ASf4BN8gu8M8Z11zxK4LJLgE3yCT/CJECFCxKuLZ0cuLp8k5CSbCA/flnE14BblL7wQ8UX/OrsE7l0wguObWJuQYSYsgGWrEl+dD1K/2b9MtJqLYeGzmQmpwkhwSSjnM8O1Y34r/VT4Koz/0j84vshwqPRbgnRRC1K/2HCI8k+ECBEiRJw4hoJuUMy/CL7A4gEbStSDbDDelNjfw8O38Vaq2A6ywXMj1Q/Gw8OnwpHffz/JJReAGx6+BMBYsC22AJohSsAiOME2qMBImE4wVfCCbTDGC6OEJgZGg25x+WGY+AbPB93i0+0w8cXTQbfYqIeJj1lBNxgVnj64COr7EK/mG6M/3PsG4J6lV2eaBZ/gE3xnlU9++Zti0aH+5JNTLOP76NJuXZoNqzvfC7UUw873FK83ZY2ZO9cJu3wtdhgf6zu+y78oehmtqYFXKsM9mJFqLjOTc6NeLlNnpRudVdziyDdDi2zK1Oy4eV6+rLX7h2+iUv1oTHWG5Tz2z1ZzkepA2lRAMotq3qjzVVx5dutHxIf9U3XXr00/8fqHb3pU+jAfzesx4quxAnVSmwpI0g9MS51V3K9c+V2fL0KVIyNe/5xf8gsS6cf5PNLP4vrJax0+voq7QPployt2G/VrXesvPiZR/hGfyvOP81H+cb7OKi7l35K2stXJv37iE/5F8Am+3vIVnUOeY58JPl4LeidK+//YfhmbnVrl/cl34LOXuunXfQujvuDjlcg9HObc4khb45vc3CijF+1U55GdAlyEJNUqxxHxxgvrP/3AR34S1Vnk9QHJhKLnpL1uqDqPYXdKXFc3qVZ5bI12zOk3Pu4nGZtCUNklE4M9lPa66VTnoRLlMRPu8Vrl6VI83Yf6tfb0Q755VqK9bvzqPKRfZLt6j2qVy2v9yMf9JPPzD/mqqRIranm/Oo/szMEFMB8s8/zrRz7hXwSf4BN8gi/oFvSX7pycL2Fqnt7F4J4C3yV4/3h8/uzvvirrx+eLbKM5OnU+mh+MpeKTp8DnMBXSptZMmcf7EkxgfOo2a31rJll5lP84IZe5D7N8wrqtV9g82hq+1yZ2sGQZlmh2G/a+9vM9+md5pKmTjMnT1o/KkH7i2Pem2XrzOWNZK9uemPeLjT9IV+KrfK9NPo1o0Zaa7on0ow0e9XO8iOYp83H9jMZ9l1VBo6qIZUjyCWtXV37mYm/ie22yeHlKsmhLTetk/dNTnVRsPIJ886d7fqH8U4wG148RX7bdmbDGi4kvrAqjHTVVunzPSh5tqWkp2yfgGwStXsb8Q75q6tTPn8hXL2L+JYlPhRSfsG7r7HWavf5S0wcsJkNKBdpS04qdJP/CPb5/IPyL4DtTfAc22NaPbCR/enwHSubaRx38wXz0BP74xKR7Cny0x3SuG59idD5qLmC+vXF/mJ0K30sI9gG3+b35iiP/fMgS4zRzpStw83/sncFzE/cVx3/a1Uq27IOedivJNod1VIVAe9DaxhYoh1XsSYebWGaalnKQQhAZcllhF/DkItm1m4QLBqYiJQe7mabDTYFAx9OLGc8w0/+q771d2XIwttsxsKv+fjNYsrQ2fHj7077f2/f7fr+HKjmsxyEdX0uRY+WckSG3IDHxlzcbP/wblUn9KUxlIZ2zSuxl5DkbWWQA34CGXRsRA/xmDPD9BpQiVmaxkzuQ76PS01+Nzi99DlnM73L/msiJBDmsC9F4tsWOlXMpQW5Bb2H+NZ4UNxf4/MzdabOXkedstF4nZXIz8lHRy2vutDE1LZtiIBMxT6nuzIF8H2OCNzFTN6lyjIn6+6v6LXJYj1vwJ+sSOVbOJcn3sv7m8zOqTqsL/vybYS8jzxlH5PAp8n1c9c/PGUxNy+LvkInY5aVPCofFzzxV/Xad8zuMn1DO/ZXXgY2mqJNj5dvio+o08o1FkzmPj1somG+a4rflxY/fxNS0LK4MId/20H3zsPnX2bC38Snmdzj/xsElh3UFrBU4x46Vb4kP/0bk+9KaSj5OM59CLRTEB0V8Gsf5d2FECH4TU9OyOK9nIjAl/t3536/v5YBf3+nT3xF9zRcfk/mn5Hv7fPu16Zb7im8nD/NTs3Kf8Yn+4sP8c8BKx+Aupr+Z6VlI5tneHWzRgIW1tvD83fcXbglH/BrPKyLXJEuctLiH56dWKa8W2Ktq0FzseP7uXBsNZ/wsWCbDzTj18A5kic9sLbvM12pGmp6/O9dGQ8mH+edqN36GuKcw32p1A/m2Bs1THc/fnWujoeTD/PMrMtyk+WeIhs5831gWpije/GN/d2XfvfAhvr5vNPs5f4lCSuZnki8gfHu6O/dp9dxbOes5IHR85d5GXb+G2VsZzPtHG2GN3yF8Inx8VP+sYNq5DFv58UYLPp3Uf9JHaidIrmUJs86dyqcQzsU8tfRO6s8hG6b880nlu2iynniQs+n8LG4uGGqlQfFjucdu5ZM2k+UHt8p4gBum+Fmw9DtMO2fEJ3lv/qkLSc0sEx/LdXYrn1RSylNLb0UNEx/XPzHtrCcM4iv08Lkcv27lk/m4pVd1M6HKP5cqmHbS/BPlxNqnO3y8m2y38sl83NKrurUwzT+mLBz1x3JhzF/GR+yj/dBew02Zn0k+ySf5JF8f8vW7/tI7GP3unyP5JJ/kk3xvZgRMP/nYR8D0k49/BEs/+fhHwPSTj30ETD/52EfA9JOPfwRLP/n4R7D0k49/BEw/+diH1E8OYlLZ5+v3oNZfJJ/kk3x9yfcauTQeB2yWG7DMYPKpkG720u3l2/0+fzDfcCWg8VPdldJBfN1nh/DFzMDyibYGf4hB6XtcoXMPTaemd4RmpeOe+N0suDrcpiYMHdwa3B6NjvnbHamdpqJtCd5r2Awsn0N7GDsTOS9+xc0bJdUUWnVj3RO/a8fvppQCxQ8fRKzw29h1f7vjk+Lm7Swm3rzXMMDxq4v3a5Be1V0+P9WbVGvRzMgtT/wOIGvEmQ8fTkHhfOvP/nbHpYrqOi+F4L2GwZ1/BY4fN2JwD80NmpCa2Vj2xO/aDJZjvmJmuKCeSfjbHYlvFp8HOn6Q7vD8y4yDK7iHBieZKzRIKZ743SyQwPbjNGNe0AtxQ/jbHYlPrVBnxrnA8r22oGQe7Vds2uHMX47Kty3zM8n3Rvm6egxs/OFE7P0PfU1eWjYCzhexu0Rs/LHLt/MP915RKjvqzL1IEyI0fGz8cXj89mpoPQg6Xw1apLacEZ7xh7OjrkEKGlELz9nInD6yPg4VR4HRGok0057/iJUZhlERg6J1QnGygY6fmRt0F33jD6errlElBY3BLeoFnjO06waenxs2SaE5rLmBPxRx6SwmDeepgJ+f8y3A9J+NP5wddQ1SYGg1mS8Zu4Z5mjMvWJ2ZNTfwhxTrC+TzNZyDy+eS2jKFgo0/nB11DeIbNMc9vuujMYofqTNf9uJnI22b48cazoHli0HLno9aum/84eyoaxBfHCyPr1rTef5h+tnw5p89v0n7Kgxfwzms1/dcX+cve1u2ZX4m+d5h/vlfDScsfLv5We8gTbXe3OyV7JolcuxyePkOWTs4BwQ+kPmnlp+GDMtXpGMVdR6mksukEMuveVXQD6wTLHgBv8HroaPCuRo08OoXxey0bAc+/9SKQlzRqhs/VL/+wdMcu8qHXNEq5SWyABGYadqi8bwQYT7S87XJkQ6z02qw+Tj/XDGVNV0zSWP5psc3Q2cmvdbyLEAw07xFghceH+v5kiPdAn4XgvwTMdxtzWysVoVSOE+aahQ/fq3FFiAYv43ZLXx/Yy67XHVIz9clRzrK3gIcv27+qZkaTGqQwvn1lXWWNNVo/tFrZostQGj+UUXUsuwL96vOMkzHvPkXbL4940hFwUPlLULNdwR5C5mfST7JJ/n+r/iew4mDV0B+1XrIEOo4QOaAfvqg8UVgVIjJzuzRVnh1Ue5oZrwQnvgRH6lBYyKj5SecbI1USP4BGfI3ixoZoZzVfzK4alYuu2KxUxfh44sWPL6iMqWU1F/imsBhf8E5vJqTg3WKq55lvP4PfvmA+EJ2fiayHp+pVGIAn3krIF4d0PJW+yzJVWtarw9fK4Qsfjwmm7MR9yLxKSVBOfNl9hecY76vEZPjhwcmdDOMfCvwnUKLBaWCS3pa0zW8+Ud8kMYHnn90pNUM2fl52DiopVDyyfxF8kk+yXfA8MsWUbDDy7cIl17NpH+0ucHF51N3qzP7Wp4EOT8bygxde5UvVo2O7fIN2j18ImR8KSqFluriMn7Nj7N6Wl3EH8WqdIvi5COldGGkpl8VM+xNnoJ0PrrW1qx0aNZ/f4QvyKLlmyx1YtusmV0Xor1pC6WomTPqwpiI2MRH3uR0fg6ai88q5WZY+MTQhzVIa7+u4te85yeIfC/nKcvWzPy8eHHP4yNvcuJrNSMrZqsZks+X6KUh6sGOf2vj17znJ4h8GxO8/DM38XGjZeeibfYmJ2HDQfPUs/DwDdSgSkKFZ+iWX16wZnYNDBWXhUPWfXP4UZTuFy3rxBddSz325l94+I52Bezb/KXRkfmZ5JN8kk/y7c8387pjuq0+VDvDy2Lzx0LY+Dg/mznsWOLbXl+xcw9CykcbMp1sDUzanenfehiwYC7ZgGrOKlGLbxuPnqh3jSM7Nf2fyVjVuTgx1H4Bf7N0r6c+uPFrPJlSHmqnaXemf+shViCzv/gYuUPiAZitRcfOd4S3d/NGST2JfBeb8/FCBpcZLfMq99QHNX60IRMXCydpd6Z/60F1kW8esuwuyPGLkYe8t3fzJsA1ip/YnHVz6SeViJ3nnvqAfr7whkxcLJym3Zn+rQd++DDOfBi2bXtl0VUK/t7NGyURpVYmoZzFxf0N4uP/gkDyWZCiDZlDlm7S7kz/1kPCsuaS4zrxPdUpeOlFMTDa3btZA5damXDxP7Smc/y4pz7Y17+n7p5vj2LGE30Unuv7Xp2zo5nxqFsyf5F8ku9d8b2ASjj4etrmjVcLL9wRM578+ZEiAUbw+VZgRhh7+ZwePsf/M2R4r/R4fQaez+9fGl83Do9fIvlKpDGmwedLjInYS8joI+uz4GamWevFUeAX3i2GzLTzDO46saJQ4aqJb/len6IGp+mA4PPFk5hrGlFDq7bjdwkppRScDZcNPaGaFg6mn85Viptm4lu+1+fSQ+09Wu6GI35beH7GPie5F8FaIc68yHslakM4wyPm7x96fEa86Ht9rla1D2ozQefjQfMvQ31LbW/uER/ruvh8IpG9fKXp8xV8r8+l0lO6FyFC8vlZyyAfyb34fDE4s8NXhqoTO9fl870+71j6eyRcGwK+/Uf9sAN+ttoIF58GxUN+wb6qyjL/lHyST/JJvtDzSf+jNxtqySf5JJ/kk3yST/IFM6FJ/oe983lu2kzj+GtZP0ySg59I2ErCwRmvukuHg5QCSRMOFmG6w012B+huc5AJcZnOHmwSYDN7sRtgC91DwnRrIHtwYDuQm9NsmWa7hwBbDvtX7ftIxnEch8aOY0ue9zlk7DivRp9831fvo9evvk+Pq8T4GB/jY3wsWLBg0a0Y0PuGm240atc8Fejt6B+r22d1kDhZ9A0fufjmJyMirQw20yZ+ctPZ7+uHEBXRvv99cxrGt2Y/HBYtX/Dx4SDAgvHHpvg4+K2O5iq+4BNtcoDvbHfxEcNH+oUMuItP3jbDl/PN+GPBggULFi0HW39hfN6NUClAXjTZ5gEJ9+X9cgd4PHdzpMk2G1eiybJfBEy/x5Vuv5sqgIhvOugaQLOpch/AsG/4hIb7Od8fSbB8wyfhZuMmIwdZ/8wPK8tNNzk25KP579V2000GTviIr9D8VBZSfcTHt9AmwdL2zkaL2zqd/LSJv+1atJYQB5rIvwOMj/ExPsZXPaFE7/K9yu7UKCaudanWQ3z9f7f26NdLfNIjFV2W5KH0Cc76FGxtAIYhskRfjOZ7gU/YTolW4IIStHKcdYlXtUCW6pcJPYknekK/AsiOy5IQMzkrFVLRQ0kjBrqA9gRfnGzdQpelKh8hxTh+idsjfGNE/BJdlqp8WzC1Tsef2iN8LH9hfIzPY3zmAfhSvuFLvXOzqeerdbF5xxeAvNsmVXeMynt0xPEcHzk4X+V/sZePeI8vBJVSY4oIy6NyyZBLo2CNhVTTdfjcBL0BH24xlCBKc1UssYpOP2m4DdEUB5MBI4rr9d7Rr7DglBpT4vk+3EYW/F+Uc/hch8+FhvoJ245eNFelWSo6/SwTUad6rpfeBmJxL+nXl3RKVaWwuJik81Np+EJ3+VyHz8Z8PG4xpDwh1XDMX3j1JCBfDuQAljDzDp+obyDfTEW/KyPBL6mKlznVdB0+F0Yajz+anc4gn7PVUBmYiA7oM6gfQb5t7/DxK4ZbakwRcPy9MGQ7LVumrJquw+dfDL3B9dPZYpiLUj6apRICciIp6zkcfxHKJ3lq/O0N0W5yfld8Nb8n5XxP87H80w98Uv0mZLNxETxO/3W+atNUdRWu63zB7LsMunJOlZMMqURQSfJvdtAO/kYlc5W0qzqnBRpgVV7Qm//A7yv7E7rON19/h1DDdyIEf13eWt74J/LN78tH6vhc/U56g+9PxJDnyIxpTAYS6aECTJncZwo/4vD94T/Jb4ZvTS7yyLdRwoI61ZzSPXHeGNRGcwW4bkScpldWaT9G/RKV/0fX+a5Q/Qpfq2YpEzg/QWWLUhEydOZDvrnFXP7q69dveYDjJIjdd7ZOPyyAlKAt8LkHp+l4MOvyvZz0Dp9wyjZJPPCJTb4HPMmLhbzD90XEzH8weWvc0Y/ycStyHZ9TwIq2oFRuU23eHX+Jyv4LD/RPs8x/XDLJWdRvth9PUjjrjj/7WzO/vrw18q5/FrJvqjllVT/k06l+blMsb+X2T+KV68umTM4QEyYCieTQRRlPUlLwhhAu2cTMH7ODOl+5vgjwkVQ3/lYGKV/fCh1/btOBVY/pR3sW6f9290W04QyYOtD8Xl/eyhPz+4C+m+9+trX5newtb8XyM+/wba32IF/N2th80Z98O9eEXRcW99c1fKlfepqvTy2UfMmXg5vahBGRgOaQc8Zx49HO8qUIg/TNj7A8DVnREmyf6idMiPb9Esn9YAlWLjG2s3wZz6P1tVkmRWl5Kyut+pUvFgS4jQudQsysXb7MkNQ8mR4Y+h2AmoPaezo/8W0LMXrHgAudusO3s3wZ/3mM6keHXtHH858EN2MhKh4YD1bmkG9n+XJzaIyOPxPQy5ytLzE+xsf4GB/jY3y+4Ov151c80R0YH+NjfIyP8TE+xue3XMc36UxbxAkwPsbH+BgfCxYsWHQm3pC10uGPwkXImDf5NmPn2nAU7nHWo3z8P6aWwF6E2OH4xlbx20QvAqYTmdCTmcPqN/Wd822wB8PEx+Cnjx9uEHL66OA8mfYmHz5gJNqH5AsOela/JVCT8mH1kwY9Ov5YsGDBgkXLEW7HQdj6C+M7kmiLOXkrrugdiraYk7fiit6haI85eQuu6B2K9piTt+CK3qloizl5K67oHYq2mJO34oreoWiPOXkLrugdivaYk7fgit6haI85eQuu6J2KRDsOwhMWRxiB1jZFOKkptC+Oju8QqXe422fB+Bgf4/Mdn3J4vqobRcXodsfMkA93k28gWuXDM8OnjxtaN+zLZ8ruYS+E3UNU+TRP8G1d2qNfc3yV0/eqfouF/BIopvEdbGuCEeGsV7CGVj1cSj0oH22Gnujhsf6ixsHxYKzwNcj/CmsFiE5Ddhq6yjcjxOaIYibOSGFNsMyvrCjVT7TvPz19YP1os3sW7Z9xTtfWEhrly5PCAu2f3FRRWn7YVf1CAPo45SMpOmCEWOErKx75wQoC3LAOzhcrLKEn+tZ0VpsnyPcAnSo1MvsTgKp2lY/T+4uZvlo+cuyGLtp7BuH7+e6hJ7r4cVlbK80J9ug9dKrURIsUCXnIdZMvGCOZZ3IN3+cr8r9XruNj8ge+ftJmD9ATPTRINBHO8GDcQadKzYTBadBzclfHH8tfGB/j8xZfoyt6k3wc7DnOrncd5BNi9fWC3p2J2QJfxUhnI4FWy+HaDL57fPvpdwi+NbKbryv6oR2k8SQHuUR6iIPJIEy66eOdcA7suDFlyPvw5XCj4Yc0SUXfn9XkkLDbEUiAz40IOlHKQyWagRJeiSrP4Fr4GW3SUf1CUTNxmfbP8xPE2TR2bi2rOXxEGol/U9xfP2lkBt3g1ktvzTI/QuodgX4eMx39FMGmGSjhB4kSJ/zw6R0DuY7woR0kyVC+T2wyT6ZfQsRNH++E57Egy/i+fPTj6eMv0uM5kAeGYq8e7nEE+sDlC4vXaQaKPVO5Jy8MbYfS453kQztIyrdd0S9XPuumj3fC5ySHr7wPH/2Y0Bw1vl5Cyy2ydnePIxDyRSmfXXRHnkK408pDrN/TQT60gyQZiY6/JI6/JThbSR/DozLybe43/ujHSfkpRDmImHANIsJuRyA6/pAvHaV8aAqEfKP0jmL9avW7s67Nf5ment8FmGD5GePrNt98qT5h0Rr+bXx/PmV3IRehdlNB0tq7HFe3HnC0fOPVXEnZxVfIk2ReUN+Ss2TMzItWJdlK/TrfYjlVnS0rFn8N+TjLfXGkfJJed4dQy7ddUBf7H/cPI5+kH5RPq8lW66Sq4+uAfuJ2EM5awn9luaSI8MhdrEzQ2ZzyXVr9Rd14Pvt8Gfn6h3E/0m2ctd7xGXJJhuwSUL5P0fIuS3+KMAnRlCE/A5uEjBMFOgWaxqRpLqwUcUn1I/mlJby20rgWOgpXrWmIHS2fkOXDIbVwZyn8gDAAAAO0SURBVFi0lXieOIuVop1x9Lt8paiKp06dsk0Ai+AiKFbLqdEvuD3I6XOo3+W+YZpdXuLVeHlMI7R/4nAV7fXzVCOzlDFjx2KLP9prTye2/qziwpyoP3T658Oj1g/5SOotH+Z0JeOW1dH4R6rLl7umcrPPZ7OoH/I51XKqfP1psBUJl0yxf0ZpdpkKqWmIOHz35CwJZgVcOqWwJj1c4G4scMMKZlNvOeskTKjI95l69P2T5vzTT/hwEPVzyupo5FPb5Tt2Qe173L9SrvTPkFMtp8onjQSRL9OHfBJaTlK+eJkgXxlvKUR7zdGP/L+98/dtGoji+CW24yTtkGcfYNTFEWQok51USSEdbPFDhCl0AMRUSIgqsVAVqagTkAU2IkVUygpC6ha1YshWKf8Y711whGO3IoU6CN0bI90pX717dx8///hWfZazV7/b5Mzz6vYg/QQnwvw5CeRPd5ZcR2mqYL7lGvRFs5LteHRBeOkRUy32mVVYsL88JLecqb6sa5K+Lyanx9VspEvUlyH7zs1js4iFh/VHe4gP6z5Tsf7AoC/XK7gscaIG3Og9bzYuuv4YXaWMvPAmWjr9Yvwc57sfnmHkJX6+j8MNg+zBfOf7fPrGks8WNnPa+Gv61Hri+iaLNNLx/KU1oVR+W1+o0RhzG/iwNVyoPrUQ0xpsvPPi9ZUie1Kgb5OmiurL96e/LUpfTP7IqeUUfWw+fYrNNhLRR046u+3eQfomOTp+QxSljmcXWrBWIJdG1QU8x/SekYF6lqvWrL5nhJ3bSC2qa3ThRIzlO6yTuh9YRDIFyhVzWDS/8isCWd9wdSWx/JGTzhbS4VH9+DrXtq1Jx/OFWJ/07mzO9pEj754wJEtkknIkfxmHvMdZKWezTr6PY1tM6PMCi0jK3/pof7DcNibI+omWQVL1R046HtLh+6bWLmS2CEV3waoJfTVxneQjR752nyJZKgDmrL5VgS2oD4Guxh6LsULfg8AiUqxPZQ9wQQhkVS0y7Elq/yQnHQ/p8Kj5kf4OoeiGbmH+VoL8FZEjPda5Now7/4hJCTt/5o/jWLqH/6GauhdYROJUqG9/gDoFsi47ZNiT1PknnHSQDtNwmXqwiKLU8ezCS3dSfzq4WH8a3MpMG5ah/CFKor5DrL8e1R+ORSDVrlZTdwKLSLbklpE7i9AuELKC6ek8QX3hIypCh+fgl/yZz6bz2eMwUX3jP+cz/+zvVvBZwx7Jn1Kf1Cf1SX3/nL7//P0VGTJkyJAhQ4aMi4wfkWCgmxa0iRoAAAAASUVORK5CYII="/></div><div class="graphic_lgnd">This algorithm summarizes our approach to antithrombotic therapy for patients with COVID-19-associated MIS-C (also called pediatric inflammatory multisystem syndrome [PIMS]). It is intended for use in conjunction with additional UpToDate content. Please refer to UpToDate topics on MIS-C for additional details. While it is generally recognized that children with MIS-C are at increased risk of thrombotic complications, the optimal approach to prevention is uncertain as there is a paucity of data. This algorithm summarizes the approach at the UpToDate authors' institution. Different approaches may be used at other centers.</div><div class="graphic_footnotes">MIS-C: multisystem inflammatory syndrome in children; VTE: venous thromboembolism; LV: left ventricular; CA: coronary artery; LMWH: low molecular weight heparin; COVID-19: coronavirus disease 2019.<br/>* All patients who meet diagnostic criteria for MIS-C are treated with low-dose aspirin (3 to 5 mg/kg) unless they have a contraindication. This is extrapolated from the practice of using aspirin in the management of children with Kawasaki disease.<br/>¶ Indications for therapeutic anticoagulation in this setting are not standardized, and practice varies considerably. In addition to the circumstances listed above, some experts would also administer therapeutic anticoagulation to patients with severe manifestations of MIS-C if the D-dimer is markedly elevated (ie, &gt;10 times the upper limit of normal).<br/>Δ Refer to UpToDate topics and drug information monographs for suggested therapeutic and prophylactic dosing of LMWH.<br/><font class="lozenge">◊</font> In patients without an indication for therapeutic anticoagulation and who are not critically ill, the decision to provide pharmacologic VTE prophylaxis is individualized, weighing the risk of thrombosis and risk of bleeding. The diagnosis of COVID-19-related MIS-C itself should be considered a major risk factor for VTE. Other important risk factors include the presence of a central venous catheter, underlying malignancy, prolonged immobility, obesity, and oral contraceptives. VTE prophylaxis is appropriate for most adolescents hospitalized with MIS-C, provided that bleeding risk is not high. In younger children, the decision is made on a case-by-case basis. When VTE prophylaxis is used, LMWH is generally the preferred agent. Nonpharmacologic strategies for VTE prophylaxis (eg, intermittent pneumatic compression devices [size permitting] and early mobilization) are encouraged, but MIS-C-related hypercoagulability may merit a higher level of intervention. For details regarding other risk factors for VTE, refer to additional UpToDate content on VTE prophylaxis in children.</div><div id="graphicVersion">Graphic 131557 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
